Tinley Park, IL, United States of America

Peter V Riccelli

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Peter V Riccelli

Introduction: Peter V Riccelli, an accomplished inventor based in Tinley Park, Illinois, is recognized for his significant contributions to the field of molecular diagnostics. With a remarkable portfolio of 11 patents, Riccelli's work primarily focuses on the development of innovative polynucleotides and their applications.

Latest Patents: Among his latest patents, Riccelli has introduced groundbreaking advancements in polynucleotides designed for use as tags and tag complements. These inventions include a family of minimally cross-hybridizing nucleotide sequences and methods of use, showcasing a specific family of 210 24mers. This innovative approach enhances the precision and efficiency of molecular diagnostic tools.

Career Highlights: Throughout his career, Peter V Riccelli has made significant strides in the field of molecular diagnostics. His role at Luminex Molecular Diagnostics, Inc. has positioned him at the forefront of technological advancements, allowing for the development of products that greatly impact diagnostic accuracy and reliability.

Collaborations: Collaborating with esteemed colleagues such as Petr Pancoska and Vit Janota, Riccelli has fostered a dynamic team environment that encourages innovation and the sharing of ideas. These collaborations have led to the emergence of valuable patents and research developments, further establishing their reputation in the industry.

Conclusion: Peter V Riccelli's commitment to innovation and excellence in molecular diagnostics is evident through his extensive patent portfolio and collaborative efforts. His contributions not only enhance the capabilities of Luminex Molecular Diagnostics, Inc. but also set new standards in the field, ultimately benefiting the healthcare industry and its stakeholders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…